Serum VEGF and bFGF adds prognostic information in patients with normal platelet counts when sampled before, during and after treatment for locally advanced non-small cell lung cancer

Author： Brattstrom D.   Bergqvist M.   Hesselius P.   Larsson A.   Wagenius G.   Brodin O.  

Publisher： Elsevier

ISSN： 0169-5002

Source： Lung Cancer, Vol.43, Iss.1, 2004-01, pp. : 55-62

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Myelosuppression induced by concurrent chemoradiotherapy as a prognostic factor for patients with locally advanced non-small cell lung cancer

By                  

Oncology Letters, Vol. 2, Iss. 5, 2011-01 ,pp. : 949-955

Spandidos Publications

Access to resources Recommend Favorite

High serum YKL-40 is a poor prognostic marker in patients with advanced non-small cell lung cancer

By Choi In Keun   Kim Yeul Hong   Kim Jun Suk   Seo Jae Hong  

Acta Oncologica, Vol. 49, Iss. 6, 2010-08 ,pp. : 861-864

Informa Healthcare

Access to resources Recommend Favorite

Serum Vascular Endothelial Growth Factor (VEGF) and Bcl-2 Levels in Advanced Stage Non-Small Cell Lung Cancer

By Tas Faruk   Duranyildiz Derya   Oguz Hilal   Camlica Hakan   Yasasever Vildan   Topuz Erkan  

Cancer Investigation, Vol. 24, Iss. 6, 2006-09 ,pp. : 576-580

Informa Healthcare

Access to resources Recommend Favorite

Use of chemo-radiotherapy in locally advanced non-small cell lung cancer

By Novello S.   Le Chevalier T.  

European Journal of Cancer, Vol. 38, Iss. 2, 2002-01 ,pp. : 292-299

Elsevier

Access to resources Recommend Favorite

Clinical observation of gemcitabine and concomitant three-dimensional conformal radiotherapy in the treatment of locally advanced non-small cell lung cancer

By Cheng Jing  

The Chinese-German Journal of Clinical Oncology, Vol. 7, Iss. 6, 2008-06 ,pp. : 311-314

Springer Publishing Company

Access to resources Recommend Favorite